Bhairav Paleja

Dr. Bhairav Paleja

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2014 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
ASAmit Singhal
Amit Singhal
LJLiu Jie
Liu Jie
PKPavanish Kumar
Pavanish Kumar
GHGan Suay Hong
Gan Suay Hong
Melvin Khee-Shing LeowMelvin Khee-Shing Leow
Melvin Khee-Shing Leow
GLGennaro De Libero
Gennaro De Libero
The global burden of tuberculosis (TB) morbidity and mortality remains immense. A potential new approach to TB therapy is to augment protective host immune responses. We report that the antidiabetic drug metformin (MET) reduces the intracellular growth of Mycobacterium tuberculosis (Mtb) in an AMPK (adenosine monophosphate–activated protein kinase)–dependent manner. MET controls the growth of drug-resistant Mtb strains, increases production of mitochondrial reactive oxygen species, and facilitates phagosome-lysosome fusion. In Mtb-infected mice, use of MET ameliorated lung pathology, reduced chronic inflammation, and enhanced the specific immune response and the efficacy of conventional TB drugs. Moreover, in two separate human cohorts, MET treatment was associated with improved control of Mtb infection and decreased disease severity. Collectively, these data indicate that MET is a promising candidate host-adjunctive therapy for improving the effective treatment of TB.

15 May 2014 in Nature Communications
Verified
Journal Article
Open access
PDF file
MLMarco Lepore
Marco Lepore
AKArtem Kalinichenko
Artem Kalinichenko
ACAlessia Colone
Alessia Colone
BPBhairav Paleja
Bhairav Paleja
ASAmit Singhal
Amit Singhal
LMLucia Mori
Lucia Mori
Mucosal-associated invariant T (MAIT) cells are abundant in humans and recognize conserved bacterial antigens derived from riboflavin precursors, presented by the non-polymorphic MHC class I-like molecule MR1. Here we show that human MAIT cells are remarkably oligoclonal in both the blood and liver, display high inter-individual homology and exhibit a restricted length CDR3β domain of the TCRVβ chain. We extend this analysis to a second sub-population of MAIT cells expressing a semi-invariant TCR conserved between individuals. Similar to ‘conventional’ MAIT cells, these lymphocytes react to riboflavin-synthesizing microbes in an MR1-restricted manner and infiltrate solid tissues. Both MAIT cell types release Th0, Th1 and Th2 cytokines, and sCD40L in response to bacterial infection, show cytotoxic capacity against infected cells and promote killing of intracellular bacteria, thus suggesting important protective and immunoregulatory functions of these lymphocytes.

1 September 2019 in Gastroenterology
Verified
Journal Article
Open access
PDF file
AWAnissa A Widjaja
Anissa A Widjaja
BSBrijesh K. Singh
Brijesh K. Singh
EAEleonora Adami
Eleonora Adami
SVSivakumar Viswanathan
Sivakumar Viswanathan
JDJinrui Dong
Jinrui Dong
SCStuart A Cook
Stuart A Cook
Background & Aims We studied the role of interleukin 11 (IL11) signaling in the pathogenesis of nonalcoholic steatohepatitis (NASH) using hepatic stellate cells (HSCs), hepatocytes, and mouse models of NASH. Methods We stimulated mouse and human fibroblasts, HSCs, or hepatocytes with IL11 and other cytokines and analyzed them by imaging, immunoblot, and functional assays and enzyme-linked immunosorbent assays. Mice were given injections of IL11. Mice with disruption of the interleukin 11 receptor subunit alpha1 gene (Il11ra1–/–) mice and Il11ra1+/+ mice were fed a high-fat methionine- and choline-deficient diet (HFMCD) or a Western diet with liquid fructose (WDF) to induce steatohepatitis; control mice were fed normal chow. db/db mice were fed with methionine- and choline-deficient diet for 12 weeks and C57BL/6 NTac were fed with HFMCD for 10 weeks or WDF for 16 weeks. Some mice were given intraperitoneal injections of anti-IL11 (X203), anti-IL11RA (X209), or a control antibody at different timepoints on the diets. Livers and blood were collected; blood samples were analyzed by biochemistry and liver tissues were analyzed by histology, RNA sequencing, immunoblots, immunohistochemistry, hydroxyproline, and mass cytometry time of flight assays. Results HSCs incubated with cytokines produced IL11, resulting in activation (phosphorylation) of ERK and expression of markers of fibrosis. Livers of mice given injections of IL11 became damaged, with increased markers of fibrosis, hepatocyte cell death and inflammation. Following the HFMCD or WDF, livers from Il11ra1–/– mice had reduced steatosis, fibrosis, expression of markers of inflammation and steatohepatitis, compared to and Il11ra1+/+ mice on the same diets. Depending on the time of administration of anti-IL11 or anti-IL11RA antibodies to wild-type mice on the HFMCD or WDF, or to db/db mice on the methionine and choline-deficient diet, the antibodies prevented, stopped, or reversed development of fibrosis and steatosis. Blood samples from Il11ra1+/+ mice fed the WDF and given injections of anti-IL11 or anti-IL11RA, as well as from Il11ra1–/– mice fed WDF, had lower serum levels of lipids and glucose than mice not injected with antibody or with disruption of Il11ra1. Conclusions Neutralizing antibodies that block IL11 signaling reduce fibrosis, steatosis, hepatocyte death, inflammation and hyperglycemia in mice with diet-induced steatohepatitis. These antibodies also improve the cardiometabolic profile of mice and might be developed for the treatment of NASH.

18 May 2017 in eLife
Verified
Journal Article
Open access
MLMarco Lepore
Marco Lepore
AKArtem Kalinichenko
Artem Kalinichenko
SCSalvatore Calogero
Salvatore Calogero
PKPavanish Kumar
Pavanish Kumar
BPBhairav Paleja
Bhairav Paleja
GLGennaro De Libero
Gennaro De Libero
MHC class I-related molecule MR1 presents riboflavin- and folate-related metabolites to mucosal-associated invariant T cells, but it is unknown whether MR1 can present alternative antigens to other T cell lineages. In healthy individuals we identified MR1-restricted T cells (named MR1T cells) displaying diverse TCRs and reacting to MR1-expressing cells in the absence of microbial ligands. Analysis of MR1T cell clones revealed specificity for distinct cell-derived antigens and alternative transcriptional strategies for metabolic programming, cell cycle control and functional polarization following antigen stimulation. Phenotypic and functional characterization of MR1T cell clones showed multiple chemokine receptor expression profiles and secretion of diverse effector molecules, suggesting functional heterogeneity. Accordingly, MR1T cells exhibited distinct T helper-like capacities upon MR1-dependent recognition of target cells expressing physiological levels of surface MR1. These data extend the role of MR1 beyond microbial antigen presentation and indicate MR1T cells are a normal part of the human T cell repertoire.

31 March 2017 in Science Immunology
Verified
Journal Article
Closed access
PDF file
CCCatherine Y. Cheng
Catherine Y. Cheng
NGNuria M. Gutierrez
Nuria M. Gutierrez
MMMardiana B. Marzuki
Mardiana B. Marzuki
XLXiaohua Lu
Xiaohua Lu
TFTaylor W. Foreman
Taylor W. Foreman
ASAmit Singhal
Amit Singhal
Sirtuin 1 activation decreases lung pathology, reduces inflammation, and enhances drug efficacy against Mycobacterium tuberculosis .

12 July 2020 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
BNBenjamin Ng
Benjamin Ng
JDJinrui Dong
Jinrui Dong
SVSivakumar Viswanathan
Sivakumar Viswanathan
AWAnissa A. Widjaja
Anissa A. Widjaja
BPBhairav Paleja
Bhairav Paleja
SCStuart A Cook
Stuart A Cook
Repetitive pulmonary injury causes fibrosis and inflammation that underlies chronic lung diseases such as idiopathic pulmonary fibrosis (IPF). Interleukin 11 (IL11) is important for pulmonary fibroblast activation but the contribution of fibroblast‐specific IL11 activity to lung fibro‐inflammation is not known. To address this gap in knowledge, we generated mice with loxP‐flanked Il11ra1 and deleted the IL11 receptor in adult fibroblasts (CKO mice). In the bleomycin (BLM) model of lung fibrosis, CKO mice had reduced fibrosis, lesser fibroblast ERK activation, and diminished immune cell STAT3 phosphorylation. Following BLM injury, acute inflammation in CKO mice was similar to controls but chronic immune infiltrates and pro‐inflammatory gene activation, including NF‐kB phosphorylation, were notably reduced. Therapeutic prevention of IL11 activity with neutralizing antibodies mirrored the effects of genetic deletion of Il11ra1 in fibroblasts. These data reveal a new function for IL11 in pro‐inflammatory lung fibroblasts and highlight the important contribution of the stroma to inflammation in pulmonary disease.